Metabolic/genetics
Mix
MASLD
Acute liver failure
Wilson
100

A 7-day-old full-term female infant is brought to the emergency department with poor feeding, vomiting, and progressive lethargy over the past 3 days. Breast fed. 

Jaundiced, lethargic, and hypotonic, hepatomegaly  Bilirubin total 14, direct 8

AST: 320, ALT: 280  

INR: 2.1

BCx EColi 

What disease do they have and what do you do? 

Galactossemia

Clues: E. coli sepsis, jaundice, vomiting after milk feeding. Eliminate lactose/galactose from diet immediately (soy formula) 

Lactose ingestion 

Send urine reducing substances 

Newborn screen later returns + deficient GALT enzyme activity 

Toxic accumulation of Gal-1-P and galactitol 

Can have cataracts in first two weeks of life 

100

A 5-month-old infant with biliary atresia underwent deceased donor liver transplantation 4 days ago. The immediate post-op course was initially stable with good graft function:

  • Bilirubin downtrending
  • AST/ALT mildly elevated (expected early post-op)
  • Doppler ultrasound on POD1 showed normal hepatic artery and portal vein flow

On postoperative day 4, the infant develops:

  • Sudden fever (38.5°C)
  • Irritability and poor feeding
  • Rapid rise in AST 150 → 980 U/L
  • ALT 120 → 760 U/L
  • INR increases from 1.4 → 2.6
  • Bilirubin begins rising again
  • Blood glucose trending low

Physical exam: lethargic infant with abdominal tenderness. No obvious bile leak from drains

What study to get and what is main concern? 

  • Absent hepatic artery flow
  • Portal vein flow still present
  • HAT
    Status 1A 
  • Biliary ischemia, failure, sepsis 
  • within first 7-14 days, initial improvement sudden deterioration 
100

What is the definition of MASLD?
 

Hepatic steatosis plus evidence of metabolic dysfunction (overweight/obesity, T2DM, or metabolic risk factors) without significant alcohol or secondary causes

100

Define pediatric acute liver failure (PALF).

elevated INR ≥ 1.5 with encephalopathy OR INR ≥ 2.0 regardless of encephalopathy in a patient without known chronic liver disease.

100

What is the key defect/biochemical abnormality in Wilson disease?

Impaired copper excretion due to ATP7B mutation → copper accumulation in liver, brain, cornea

200

What is the major hepatic complication of untreated tyrosinemia type I and what is the treatment?

Hepatocellular carcinoma and acute liver failure. Nitisinone (NTBC) + dietary restriction of tyrosine/phenylalanine

200

A 15-year-old boy is evaluated for elevated liver enzymes. Labs:

  • ALT 95 U/L
  • AST 88 U/L
  • Ceruloplasmin: 18 mg/dL (low-normal)
  • 24-hour urine copper: mildly elevated
  • No Kayser–Fleischer rings
  • Genetic testing is pending.
  • What is the most appropriate next step in diagnosis?

Proceed with hepatic copper quantification via liver biopsy OR confirmatory ATP7B genetic testing (do not exclude Wilson disease based on absence of KF rings).

200

Most accurate noninvasive imaging modality for hepatic fat quantification?
 

MRI-PDFF

200

What is the most important treatable infectious cause of PALF in children?
 

Herpes simplex virus (HSV), especially in neonates.

200

Gene in Wilson disease? 

Impaired copper excretion due to ATP7B mutation → copper accumulation in liver, brain, cornea

300

What is the genetic inheritance pattern of alpha-1 antitrypsin deficiency (and name of the gene)?

SERPINA1 gene. Codominant 

300

A 10-year-old with known cirrhosis due to biliary atresia presents with hematemesis. Endoscopy shows large esophageal varices, which are banded successfully.

What is the most appropriate long-term secondary prophylaxis?

Nonselective beta-blocker therapy + repeat endoscopic variceal ligation.

300

What patients should be screened for MASLD and how? 

Screen with ALT starting at age 9–11 years in children with obesity or overweight plus additional risk factors (e.g., insulin resistance, dyslipidemia, family history of T2DM/MASLD).

300

What is the most common identifiable cause of PALF in developed countries?
 

Indeterminate (idiopathic) acute liver failure.

300

What is a key clue for Wilson disease presenting as PALF?
 

Low alkaline phosphatase relative to bilirubin, Coombs-negative hemolytic anemia, low ceruloplasmin.

400

What liver finding is typical of glycogen storage disease type I?
What enzyme is deficient in glycogen storage disease type I?

What is the hallmark metabolic abnormality in glycogen storage disease type I?

Hepatomegaly, hypoglycemia, lactic acidosis, hyperuricemia, hyperlipidemia

Glucose-6-phosphatase

Severe fasting hypoglycemia

400

A 7-year-old has splenomegaly and thrombocytopenia but normal liver synthetic function. Ultrasound shows patent portal vein with cavernous transformation. Liver enzymes are normal.'=

AND what to do? 


Extrahepatic portal vein obstruction (EHPVO)

400

12-year-old boy with BMI 99th percentile has persistent ALT 110–130 U/L for 12 months. He has negative workup for viral hepatitis, Wilson disease, and autoimmune hepatitis. Platelets and albumin are normal. Elastography suggests increased stiffness.

According to pediatric guideline principles, what is the most appropriate next step?


Consider liver biopsy to assess severity and stage fibrosis.

Biopsy is considered when:

  • Persistent ALT elevation with unclear fibrosis stage
  • Noninvasive tests suggest increased fibrosis risk
  • Decision-making would change management (e.g., advanced fibrosis)
400

What is the hallmark lab pattern of acetaminophen toxicity in PALF?
 

Very high AST/ALT (>1000–10,000), relatively low bilirubin early


400

What is first-line treatment for Wilson disease?

Chelation therapy (D-penicillamine or trientine) + zinc

500

What is the diagnostic test of choice for suspected fatty acid oxidation disorders?

What fasting-related risk is most dangerous in fatty acid oxidation disorders?

What is the long-term management principle in fatty acid oxidation disorders?

Plasma acylcarnitine profile + urine organic acids

Hypoglycemia without ketones (hypoketotic hypoglycemia)

Avoid fasting, high carbohydrate intake, carnitine supplementation (selected cases)

500

A 12-year-old with portal hypertension due to congenital hepatic fibrosis has:

  • Platelets 40,000
  • Massive splenomegaly
  • No bleeding history
  • Normal INR and albumin

A surgeon recommends splenectomy to improve platelet count prior to elective orthopedic surgery.

What is the most appropriate concern with this plan?


  • Splenectomy in portal hypertension significantly increases:
    • Portal venous flow stasis → thrombosis risk
    • Post-op portal hypertensive complications
  • Platelet count alone is NOT an indication for splenectomy
500

Most common genetic variant associated with increased MASLD risk?

PNPLA3 polymorphism

500

A 3-year-old boy presents with fever, vomiting, and lethargy for 2 days. Labs show:

  • AST 5,800 U/L
  • ALT 4,900 U/L
  • INR 2.8
  • Glucose 42 mg/dL
  • Ammonia 160 µmol/L
  • Lactate elevated

Viral hepatitis studies are pending. He has no prior history of liver disease.

You notice marked hypoglycemia and lactic acidosis out of proportion to transaminase elevation pattern.

What is the most likely diagnosis, and what is the most important immediate management step?


Mitochondrial fatty acid oxidation disorder (or other inborn error of metabolism) → immediate high-rate dextrose infusion and avoidance of fasting/catabolism.

500

A 14-year-old boy presents with 5 days of jaundice, confusion, and dark urine. He is otherwise healthy with no prior liver disease. Labs show: AST 980 U/L, ALT 620 U/L, total bilirubin 26 mg/dL (direct 12), INR 3.0, and hemoglobin 7.8 g/dL with Coombs-negative hemolytic anemia. Serum ceruloplasmin is 9 mg/dL. ALP is 48 U/L (low-normal). The ALP:total bilirubin ratio is 1.8. You strongly suspect Wilson disease–associated acute liver failure.

He is started on penicillamine and transferred for transplant evaluation. Over the next 24 hours, his mental status worsens and INR rises to 3.8.

The team asks: Should we continue aggressive chelation and wait for response before listing for transplant?

Transplant

Reason chelation slow, mental status, INR worsening